nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—AVPR2—G alpha (s) signalling events—P2RY11—narcolepsy	0.0247	0.0247	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0186	0.0186	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0186	0.0186	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0183	0.0183	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0183	0.0183	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0182	0.0182	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0182	0.0182	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—P2RY11—narcolepsy	0.0179	0.0179	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0166	0.0166	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0166	0.0166	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.016	0.016	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—HCRT—narcolepsy	0.0152	0.0152	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—HCRT—narcolepsy	0.015	0.015	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0149	0.0149	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0143	0.0143	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0143	0.0143	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0142	0.0142	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0142	0.0142	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0139	0.0139	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0138	0.0138	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0136	0.0136	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—PENK—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—PENK—narcolepsy	0.0133	0.0133	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0123	0.0123	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0123	0.0123	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0122	0.0122	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0122	0.0122	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0119	0.0119	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Conivaptan—AVPR2—G alpha (s) signalling events—NPS—narcolepsy	0.0116	0.0116	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—TRH—narcolepsy	0.0116	0.0116	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—TRH—narcolepsy	0.0114	0.0114	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—TRH—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.01	0.01	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00936	0.00936	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00936	0.00936	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HCRTR1—narcolepsy	0.00929	0.00929	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HCRTR2—narcolepsy	0.00929	0.00929	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—P2RY11—narcolepsy	0.00904	0.00904	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.009	0.009	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—P2RY11—narcolepsy	0.00898	0.00898	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00893	0.00893	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00839	0.00839	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—NPS—narcolepsy	0.00839	0.00839	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00829	0.00829	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—NPS—narcolepsy	0.00829	0.00829	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—NPS—narcolepsy	0.00823	0.00823	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00823	0.00823	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00783	0.00783	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00777	0.00777	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—HCRT—narcolepsy	0.00769	0.00769	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00765	0.00765	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HCRT—narcolepsy	0.00763	0.00763	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0076	0.0076	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00751	0.00751	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00751	0.00751	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—PENK—narcolepsy	0.00685	0.00685	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—PENK—narcolepsy	0.0068	0.0068	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00671	0.00671	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00666	0.00666	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—TRH—narcolepsy	0.00583	0.00583	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—TRH—narcolepsy	0.00578	0.00578	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00556	0.00556	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00556	0.00556	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00552	0.00552	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00552	0.00552	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00529	0.00529	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00529	0.00529	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00525	0.00525	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00525	0.00525	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00511	0.00511	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—HRH3—narcolepsy	0.00511	0.00511	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—P2RY11—narcolepsy	0.00507	0.00507	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HRH3—narcolepsy	0.00507	0.00507	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.00505	0.00505	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HCRTR2—narcolepsy	0.0048	0.0048	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HCRTR1—narcolepsy	0.0048	0.0048	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HCRTR2—narcolepsy	0.00477	0.00477	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HCRTR1—narcolepsy	0.00477	0.00477	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—P2RY11—narcolepsy	0.00464	0.00464	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—P2RY11—narcolepsy	0.00461	0.00461	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00452	0.00452	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HCRT—narcolepsy	0.00434	0.00434	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HCRT—narcolepsy	0.00431	0.00431	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—NPS—narcolepsy	0.00423	0.00423	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—TAC1—narcolepsy	0.00423	0.00423	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—TAC1—narcolepsy	0.0042	0.0042	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—NPS—narcolepsy	0.0042	0.0042	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HCRT—narcolepsy	0.00394	0.00394	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HCRT—narcolepsy	0.00392	0.00392	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0039	0.0039	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00388	0.00388	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PENK—narcolepsy	0.00387	0.00387	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PENK—narcolepsy	0.00384	0.00384	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PENK—narcolepsy	0.00352	0.00352	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PENK—narcolepsy	0.00349	0.00349	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00334	0.00334	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00332	0.00332	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—TRH—narcolepsy	0.00329	0.00329	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—TRH—narcolepsy	0.00327	0.00327	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—TRH—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—TRH—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HRH3—narcolepsy	0.00289	0.00289	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HRH3—narcolepsy	0.00287	0.00287	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HCRTR1—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HCRTR2—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HCRTR1—narcolepsy	0.00282	0.00282	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HCRTR2—narcolepsy	0.00282	0.00282	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—P2RY11—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—P2RY11—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HRH3—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HRH3—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—HTR2A—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HTR2A—narcolepsy	0.00253	0.00253	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—TAC1—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—NPS—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—TAC1—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—NPS—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HCRT—narcolepsy	0.00233	0.00233	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HCRT—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—TAC1—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—NPS—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—NPS—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—TAC1—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PENK—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PENK—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TRH—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TRH—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HRH3—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HRH3—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR2A—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR2A—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR2A—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR2A—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TAC1—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NPS—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NPS—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TAC1—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR2A—narcolepsy	0.000772	0.000772	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR2A—narcolepsy	0.000766	0.000766	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CHKB—narcolepsy	0.000449	0.000449	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000305	0.000305	CbGpPWpGaD
